🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

All American adults to be eligible for COVID-19 vaccine by April 19 -Biden

Published 04/06/2021, 08:34 AM
Updated 04/06/2021, 05:16 PM
© Reuters. FILE PHOTO: Coronavirus vaccination site at NYCHA housing complex in Brooklyn
PFE
-
JNJ
-
MRNA
-

By Trevor Hunnicutt

WASHINGTON (Reuters) - U.S. President Joe Biden on Tuesday moved up the COVID-19 vaccine eligibility target for all American adults to April 19, but warned that with new virus variants spreading "we're still in a life-and-death race" with the coronavirus.

Biden directed states to widen the vaccine eligibility to people 18 or older by April 19, two weeks earlier than the May 1 deadline he announced previously. No COVID-19 vaccine is authorized yet for children under 16, although testing is underway.

Most U.S. states had already said they would open vaccines to all adults by that new target date.

"What we do now is going to determine how many people we'll save or lose in the month of April and May, and June, before we get to July Fourth," Biden said at a White House event.

More than 80% of teachers and school staff had received at least one vaccination shot, Biden said, but noted that variants of the coronavirus are spreading and generating a rise in cases.

“We aren’t at the finish line. We still have a lot of work to do. We’re still in a life-or-death race," Biden said.

He said that by no later than April 19, every adult 18 or older will be eligible to be vaccinated.

White House spokeswoman Jen Psaki said Biden's announcement had confirmed for the public that "everyone is eligible around the country."

This means Americans no longer need to check with state and local websites to see whether they qualify, she said.

"No more confusing rules," said Biden.

Vaccine supplies and efficiency in getting shots into arms have increased significantly in the race to get more people inoculated as more contagious virus variants circulate.

Biden spoke after touring a vaccination site at Virginia Theological Seminary in Alexandria, Virginia.

"Governors - Democrats and Republicans - are working with (the White House COVID-19 response team) to accelerate the vaccination program," White House chief of staff Ron Klain said on Twitter.

When vaccine doses were in shorter supply, states initially limited distribution to high-risk groups, such as the elderly and front-line healthcare workers, and then gradually opened up vaccines to other age and at risk groups.

Upon taking office in January, Biden set a goal of delivering 100 million shots into people's arms within his first 100 days in office, which is the end of April. That goal has since been doubled to 200 million.

COVID-19 has killed more than 555,000 people in the United States - the world's highest coronavirus death toll. But more than 167 million vaccine doses have been administered in the country. Four in 10 Americans have had at least one vaccine dose, a rate far ahead of most countries.

The authorized vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech both require two doses, while Johnson & Johnson (NYSE:JNJ)'s is a one-shot vaccine. The Pfizer (NYSE:PFE) vaccine is authorized for those aged 16 and up, while the other two can be given to adults age 18 and older.

© Reuters. FILE PHOTO: Vaccination center in California

U.S. vaccine distribution began haltingly under Biden's predecessor, Donald Trump.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.